Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 457 | 477 | 561 | 491 | 385 |
| Operating Income | -457 | -477 | -561 | -491 | -385 |
| Other Income | 0 | -2 | 0 | 0 | 0 |
| Pre-tax Income | -457 | -480 | -561 | -491 | -385 |
| Net Income Continuous | -457 | -480 | -561 | -491 | -385 |
| Net Income | $-457 | $-480 | $-561 | $-433 | $-385 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | N/A | N/A | N/A |
| EBITDA(a) | $-457 | $-480 | $-561 | $-491 | $-385 |